Publications by authors named "Harold Moses"

Claim this Profile
N
New onset lymphopenia in patients with relapsing multiple sclerosis switching from long-standing dimethyl fumarate treatment to diroximel fumarate: A case series.
Megan Schneider, John Kramer, Aimee Banks, Harold Moses

Mult Scler· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.
Hanane Laklai, Yekaterina A Miroshnikova, Michael W Pickup, Eric A Collisson, Grace E Kim, Harold L Moses

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): History and Highlights of 20 Years of Accomplishments.
Tuya Pal, Sarah V Suiter, Harold L Moses, Duane T Smoot, Ann Richmond

J Health Care Poor Underserved· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
Makoto Sano, Ryota Takahashi, Hideaki Ijichi, Kazunaga Ishigaki, Tomoharu Yamada, Harold L Moses

Gut· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome.
Hironori Hara, Sonoko Maemura, Takayuki Fujiwara, Norifumi Takeda, Satoshi Ishii, Harold L Moses

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.
Ryota Takahashi, Hideaki Ijichi, Makoto Sano, Koji Miyabayashi, Dai Mohri, Harold L Moses

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid Cell-Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms.
Georgii Vasiukov, Tatiana Novitskaya, Andries Zijlstra, Philip Owens, Fei Ye, Harold L Moses

Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
Erin P Balogh, Andrew B Bindman, S Gail Eckhardt, Susan Halabi, R Donald Harvey, Harold L Moses

Oncologist· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment.
Makoto Sano, Hideaki Ijichi, Ryota Takahashi, Koji Miyabayashi, Hiroaki Fujiwara, Harold L Moses

Oncogenesis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer.
Yael Raz, Noam Cohen, Ophir Shani, Rachel E Bell, Sergey V Novitskiy, Harold L Moses

J Exp Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine tablets added to IFN-β in active relapsing MS: The ONWARD study.
Xavier Montalban, Thomas P Leist, Bruce A Cohen, Harold Moses, Jackie Campbell

Neurol Neuroimmunol Neuroinflamm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Robert J Fox, Christopher S Coffey, Robin Conwit, Merit E Cudkowicz, Trevis Gleason, Harold Moses

N Engl J Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY).
Stanley L Cohan, Harold Moses, Jonathan Calkwood, Carlo Tornatore, Chris LaGanke

Mult Scler Relat Disord· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.
Dina Polosukhina, Harold D Love, Harold L Moses, Ethan Lee, Roy Zent

Oncol Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
Jeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, David B Clifford, Yunxia Wang, Harold Moses

Neurology· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.
Michael W Pickup, Philip Owens, Agnieszka E Gorska, Anna Chytil, Fei Ye, Harold L Moses

Cancer Immunol Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
Brian D Lehmann, Bojana Jovanović, Xi Chen, Monica V Estrada, Kimberly N Johnson, Harold L Moses

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses.
Jiqing Sai, Philip Owens, Sergey V Novitskiy, Oriana E Hawkins, Anna E Vilgelm, Harold L Moses

Clin Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.
Michael W Pickup, Philip Owens, Harold L Moses

Cold Spring Harb Perspect Biol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.
Dina Polosukhina, Harold D Love, Hernan Correa, Zengliu Su, Kimberly B Dahlman, Harold L Moses

Mol Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.
Swati Biswas, Marta Guix, Cammie Rinehart, Teresa C Dugger, Anna Chytil, Harold L Moses

J Clin Invest· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TβRIII Expression in Human Breast Cancer Stroma and the Role of Soluble TβRIII in Breast Cancer Associated Fibroblasts.
Bojana Jovanović, Michael W Pickup, Anna Chytil, Agnieszka E Gorska, Kimberly C Johnson, Harold L Moses

Cancers (Basel)· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Robert J Fox, Christopher S Coffey, Merit E Cudkowicz, Trevis Gleason, Andrew Goodman, Harold Moses

Contemp Clin Trials· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Discovery and Early Days of TGF-β: A Historical Perspective.
Harold L Moses, Anita B Roberts, Rik Derynck

Cold Spring Harb Perspect Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
Gary H Lyman, Harold L Moses

N Engl J Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis